Obesity and Alzheimer's Disease
Obesity and Alzheimer's Disease
批准号:
7241454
负责人:
DEBORAH R. GUSTAFSON
金额:
$6.25万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-07-01 至 2009-06-30
关键词:
AdultAgeAged, 80 and overAgingAlteplaseAlzheimer&aposs DiseaseAlzheimer&aposs disease riskAngiotensin ReceptorAngiotensinsApolipoprotein EAreaBirthBlood PressureBlood VesselsBody WeightBody mass indexBrain PathologyCatecholsCessation of lifeClinicalDataDementiaDiseaseDisruptionElderlyEnergy MetabolismEpidemicEtiologyEuropeEvaluationFeminizationFutureGenesGeneticGenetic PolymorphismGenotypeGoalsHealthHomeostasisHormonesHungerHypothalamic structureLengthLife Cycle StagesLongevityLongitudinal StudiesMeasurementMental disordersMethylenetetrahydrofolate reductase (NADPH)Morbidity - disease rateObesityOnset of illnessOverweightParticipantPatternPeptidyl-Dipeptidase APhysical activityPopulationPopulation StudyPrevalencePublicationsRateRegulationRelative (related person)ReportingResearchRiskRisk FactorsRoleSatiationSocietiesSwedenTimeTransferaseUnited StatesVariantWeightWomanage groupage relatedbaseblood lipidcohortcritical developmental perioddesignfollow-upgenetic risk factorintervention programmenmortalityneuropathologyprospective
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Obesity is associated with Alzheimer's disease (AD), particularly in women. However, changes in body weight and body mass index (BMI) throughout the progressive course of AD have also been reported, resulting in a low body weight or low BMI predicting mortality among those who have the disease. Thus, temporal changes in body weight and BMI may not only influence AD risk, but also progression, and ultimately death. The role of BMI in AD also underscores the importance of timing of risk factors, both in relationship to disease onset and whether they occur in early-, mid-, or late-life; and illustrates the change in direction of risk factor-disease relationships that may occur at certain points in late life. The goals of this project are to evaluate the role of BMI and related vascular and genetic factors in relationship to AD in three population-based, longitudinal studies containing epidemiologic, clinical, and biologic data related to psychiatric disorders of aging that are unsurpassed in the world. We propose to: 1) Characterize the role of overweight and obesity in AD and other dementias in women and men across three population-based studies in Goteborg, Sweden. Participants in these studies, born between 1901 and 1930, have been followed prospectively from baseline ages of 38 to 70, and 95 years. 2) Evaluate the role of overweight and obesity in AD and other dementias with consideration for 'critical periods' of adiposity exposure, the length of time between an adiposity measurement and onset of dementia, the role of current overweight and obesity outpoints in relationship to dementia risk, and examination of risk factors by age group with consideration for birth cohort. 3) Assess the role of genetic polymorphisms related to the vascular etiology of AD and other dementias, and their potential interaction with obesity. 4) Consider physical activity and other vascular risk factors, such as blood pressure and blood lipids, and their potential interaction with obesity and genetic factors to modulate risk for AD and other dementias. Understanding the life course of overweight and obesity in relationship to dementia will assist the future design of tailor-made intervention programs based on age and previous weight patterns, and assist in the evaluation of better outpoints for overweight and obesity that optimize health in the oldest age groups.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
The prevalence of psychotic symptoms and paranoid ideation in non-demented population samples aged 70-82 years.
70-82 岁非痴呆人群样本中精神病症状和偏执观念的患病率。
DOI:
10.1002/gps.2278
发表时间:
2009
期刊:
International journal of geriatric psychiatry
影响因子:
4
作者:
[Sigstrom,Robert, Skoog,Ingmar, Sacuiu,Simona, Karlsson,Bjorn, Klenfeldt,IsakFreden, Waern,Margda, Gustafson,Deborah, Ostling,Svante]
通讯作者:
Ostling,Svante
Obesity and dementia: adipokines interact with the brain.
肥胖和痴呆:脂肪因子与大脑相互作用。
DOI:
10.1016/j.euroneuro.2014.03.002
发表时间:
2014-12
期刊:
EUROPEAN NEUROPSYCHOPHARMACOLOGY
影响因子:
5.6
作者:
[Arnoldussen, Ilse A. C., Kiliaan, Amanda J., Gustafson, Deborah R.]
通讯作者:
Gustafson, Deborah R.
A population-based study on phobic fears and DSM-IV specific phobia in 70-year olds.
一项针对 70 岁老年人的恐惧症和 DSM-IV 特定恐惧症的人群研究。
DOI:
10.1016/j.janxdis.2010.08.014
发表时间:
2011
期刊:
Journal of anxiety disorders
影响因子:
10.3
作者:
[Sigstrom,Robert, Ostling,Svante, Karlsson,Bjorn, Waern,Margda, Gustafson,Deborah, Skoog,Ingmar]
通讯作者:
Skoog,Ingmar
DOI:
10.1016/j.psychres.2008.11.012
发表时间:
2010-04-30
期刊:
PSYCHIATRY RESEARCH
影响因子:
11.3
作者:
[Gudmundsson, Pia, Skoog, Ingmar, Gustafson, Deborah]
通讯作者:
Gustafson, Deborah
MACS/WIHS Combined Cohort Study: Brooklyn Clinical Research Site (Bklyn CRS)
-
批准号:10218967
-
项目类别:
-
资助金额:$11.91万
-
财政年份:2019
-
负责人:DEBORAH R. GUSTAFSON
-
依托单位:
MACS/WIHS Combined Cohort Study: Brooklyn Clinical Research Site (Bklyn CRS)
-
批准号:10370354
-
项目类别:
-
资助金额:$278.67万
-
财政年份:2019
-
负责人:DEBORAH R. GUSTAFSON
-
依托单位:
MACS/WIHS Combined Cohort Study: Brooklyn Clinical Research Site (Bklyn CRS)
-
批准号:10612850
-
项目类别:
-
资助金额:$281.33万
-
财政年份:2019
-
负责人:DEBORAH R. GUSTAFSON
-
依托单位:
MACS/WIHS Combined Cohort Study: Brooklyn Clinical Research Site (Bklyn CRS)
-
批准号:9903480
-
项目类别:
-
资助金额:$288.08万
-
财政年份:2019
-
负责人:DEBORAH R. GUSTAFSON
-
依托单位:
ADRD plasma biomarkers and cognition in aging women with and without HIV infection
-
批准号:10119421
-
项目类别:
-
资助金额:$40.1万
-
财政年份:2019
-
负责人:DEBORAH R. GUSTAFSON
-
依托单位:
MACS/WIHS Combined Cohort Study: Brooklyn Clinical Research Site (Bklyn CRS): COVID-19 Vaccine Acceptance and Hesitancy (CVHB) Study in People with HIV Supplement
-
批准号:10396763
-
项目类别:
-
资助金额:$3.94万
-
财政年份:2019
-
负责人:DEBORAH R. GUSTAFSON
-
依托单位:
MACS/WIHS Combined Cohort Study: Brooklyn Clinical Research Site (Bklyn CRS)
-
批准号:10218991
-
项目类别:
-
资助金额:$3.86万
-
财政年份:2019
-
负责人:DEBORAH R. GUSTAFSON
-
依托单位:
Obesity and Alzheimer's Disease
-
批准号:7036949
-
项目类别:
-
资助金额:$6.44万
-
财政年份:2006
-
负责人:DEBORAH R. GUSTAFSON
-
依托单位:
CREATION OF A MULTIETHNIC DIETARY SURVEY FOR ELDERS
-
批准号:2906732
-
项目类别:
-
资助金额:$6.91万
-
财政年份:1999
-
负责人:DEBORAH R. GUSTAFSON
-
依托单位:
CREATION OF A MULTIETHNIC DIETARY SURVEY FOR ELDERS
-
批准号:6174161
-
项目类别:
-
资助金额:$6.95万
-
财政年份:1999
-
负责人:DEBORAH R. GUSTAFSON
-
依托单位:
Brooklyn Women's Interagency HIV Study (WIHS) V
-
批准号:8991049
-
项目类别:
-
资助金额:$220.37万
-
财政年份:1992
-
负责人:DEBORAH R. GUSTAFSON
-
依托单位:
Brooklyn Women's Interagency HIV Study (WIHS) V
-
批准号:9211289
-
项目类别:
-
资助金额:$243.66万
-
财政年份:1992
-
负责人:DEBORAH R. GUSTAFSON
-
依托单位:
Brooklyn Women's Interagency HIV Study (WIHS) V
-
批准号:8432733
-
项目类别:
-
资助金额:$205.0万
-
财政年份:1992
-
负责人:DEBORAH R. GUSTAFSON
-
依托单位:
Brooklyn Women's Interagency HIV Study (WIHS) V
-
批准号:8827658
-
项目类别:
-
资助金额:$211.77万
-
财政年份:1992
-
负责人:DEBORAH R. GUSTAFSON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: